Table: Rohto - 6-MTH group results

Rohto Pharmaceutical

13/11/2018 06:00

Nov 13 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2018        Sep 30, 2017     Mar 31, 2019 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               87.26               78.50           183.30    
                   (+11.2 pct)         (+10.1 pct)      (+6.7 pct)  
  Operating           10.71                8.66            21.40    
                   (+23.7 pct)         (+33.9 pct)      (+12.1 pct) 
  Recurring           11.08                8.75            21.80    
                   (+26.6 pct)         (+28.3 pct)      (+15.7 pct) 
  Net                  7.32                5.65            13.30    
                   (+29.6 pct)         (+34.8 pct)      (+43.2 pct) 
  EPS               64.22 yen           49.58 yen       116.71 yen  
  EPS Diluted       63.96 yen           49.37 yen                   
  Ann Div                               22.00 yen        23.00 yen  
  -Q2 div           11.00 yen           11.00 yen                   
  -Q4 div                               11.00 yen        12.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T